HPV vaccination in the UK

doi:10.1136/bmj.39555.668229.80

BMJ 2008;336:1028-1029 (10 May), doi:10.1136/bmj.39555.668229.80 (published 24 April 2008)

Editorials

HPV vaccination in the UK

Acceptable uptake is possible in schools, but important practicalbarriers exist

The first 150 words of the full text of this article appear below.

In the accompanying study, Brabin and colleagues report findingsfrom a pilot study of routine human papillomavirus (HPV) vaccinationin advance of the implementation of a £100m ( ${euro}$ 124m; $197m)national HPV immunisation programme in the United Kingdom thisautumn.¹ The study achieved 70.6% uptake for the first doseof the vaccine, with a drop of only 2.1% for the second dose.The third dose has yet to be delivered, and the authors emphasisethe crucial importance of maintaining high uptake for the finaldose.

These are the first published data on the uptake of HPV vaccine,and they are both encouraging and consistent with studies ofintentions to vaccinate in the UK and elsewhere.² ³ ⁴ However,uptake was lower than the 87.2% achieved in the same age groupfor a school based meningitis C catch-up programme in 2000,⁵or the 91% uptake of the first dose in a comparable study . . . [Full text of this article]

Jo Waller, senior research fellow, Jane Wardle, professor of clinical psychology

¹ Cancer Research UK Health Behaviour Research Centre, Department of Epidemiology and Public Health, UCL, London WC1E 6BT

j.waller@ucl.ac.uk

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati What's this?

This article has been cited by other articles:

Shin, G. Y. (2008). Effect of ethnic group should be clarified. BMJ 336: 1146-1146 [Full text]

Rapid Responses:

Read all Rapid Responses

A Multi-Cohort Markov Model of Anti-HPV Vaccination Programme.: Giampiero Favato
bmj.com, 29 Apr 2008 [Full text]
HPV: Predicting the Unpredictable and legally taking Liberty of Happiness: Dr.Basavaraj Shivayogi Hadapad, et al.
bmj.com, 7 May 2008 [Full text]